المؤلفون: M. Yalçınkaya, Elif Aksöz, Veli Yilgor Cirak, Mehmet Özüiçli, Cengiz Gokbulut, Dilek Aksit, Oǧuzhan Korkut

المساهمون: Uludağ Üniversitesi/Veteriner Fakültesi/Parazitoloji Anabilim Dalı., Özüiçli, Mehmet, Çırak, Veli Yılgör

المصدر: Journal of veterinary pharmacology and therapeutics. 39(6)

مصطلحات موضوعية: 0301 basic medicine, Veterinary sciences, Veterinary medicine, Resistance, Area under the moment curve, Administration, Oral, Strongyle Infections, Equine, Horse, Drug milk level, Persistence (computer science), 0403 veterinary science, chemistry.chemical_compound, Drug blood level, Feces, fluids and secretions, Ivermectin, Time to maximum plasma concentration, Mares milk, Mean residence time, Drug feces level, Cows milk, Eprinomectin, Abamectin, Anthelmintic agent, Priority journal, Anthelmintics, Area under the curve, Analogs and derivatives, Antiparasitic Agents, 04 agricultural and veterinary sciences, Moxidectin, Chemistry, Blood, Milk, Area Under Curve, embryonic structures, Female, medicine.drug, 040301 veterinary sciences, Mare, Donkeys, Administration, Cutaneous, Article, Excretion, 03 medical and health sciences, Oral drug administration, Drug formulation, parasitic diseases, medicine, Animals, Animal experiment, Cutaneous drug administration, Horses, Pharmacology, Macrocyclic lactones, Antiparasitic agent, Feces analysis, General Veterinary, Maximum plasma concentration, urogenital system, Pharmacology & pharmacy, Protein-fraction, Animal, Body weight, Nonhuman, Drug efficacy, 030104 developmental biology, Correlation coefficient, Metabolism, chemistry, Pharmacokinetic parameters, Clinical-trial, Cattle, Drug disposition, Parasitology, Horse Diseases, Mare milk, Faecal excretion, Controlled study, High performance liquid chromatography

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c16e8d42284c9c07e77782f70f3392Test
https://pubmed.ncbi.nlm.nih.gov/27016093Test

المؤلفون: Begg, E. J., Gardiner, S. J., Kirkpatrick, C. M.J.

مصطلحات موضوعية: Breastfeeding, Drug milk level, Human milk, Lactation, 2700 Medicine

الإتاحة: https://doi.org/10.1016/B978-0-08-046884-6.01126-XTest
https://espace.library.uq.edu.au/view/UQ:723577Test

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/ İç Hastalıkları Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Genetik Anabilim Dalı., Ali, Rıdvan, Özkalemkaş, Fahir, Kimya, Yalçın, Köksal, Nligün, Özkocaman, Vildan, Gülten, Tuna, Yorulmaz, Hakan, Tunalı, Ahmet Semih, AAH-1854-2021, AAG-8495-2021, AAG-8393-2021

مصطلحات موضوعية: Male, Fetus risk, Blood sampling, Leukocytosis, Child growth, Review, Treatment response, Drug milk level, Piperazines, Infant, newborn, Targeted therapy, Issues, BCR ABL protein, Umbilical cord blood, Drug blood level, Teratogenicity, Pregnancy, hemic and lymphatic diseases, Antineoplastic agents, Hydroxyurea, Obstetrics & gynecology, Disease course, Treatment outcome, Cml, Child development, Vaginal delivery, Cancer, Drug tolerability, Prenatal drug exposure, 2 [2 methyl 5 [4 (1 piperazinylmethyl)benzamido]anilino] 4 (3 pyridyl)pyrimidine, Patient, Chronic myeloid leukemia, Anemia, Puerperium, Infant peripheral blood, Prognosis, Management, Amnion fluid, Female, Safety, Human, Adult, Breast milk, Fetus echography, Maternal blood, Breast feeding, Leukemia, myeloid, chronic-phase, Milk, human, Cytogenetics, Case report, Mesylate, Humans, Leukapheresis, Apgar score, neoplasms, Chronic myeloid-leukemia, Spontaneous abortion, Fetus growth, Gestational age, Philadelphia chromosome positive cell, Leukemia remission, Labor induction, Chronic Myeloid Leukemia, Imatinib, Thrombocythemia, Pyrimidines, Pregnancy complications, neoplastic, Drug determination, Drug tolerance, High performance liquid chromatography

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______9458::058a8c3f7f625c3492c6b8261cde5ab5Test
http://hdl.handle.net/11452/22815Test

مصطلحات الفهرس: patient referral, pregnancy outcome, pregnant woman, prenatal screening, priority journal, puerperium, United Kingdom, vaccination, vertical transmission, virus load, virus transmission, adefovir/dt [Drug Therapy], adefovir/to [Drug Toxicity], entecavir/dt [Drug Therapy], entecavir/to [Drug Toxicity], hepatitis B antibody/ct [Clinical Trial], hepatitis B antibody/cb [Drug Combination], hepatitis B antibody/dt [Drug Therapy], hepatitis B surface antigen/ec [Endogenous Compound], hepatitis B vaccine/ct [Clinical Trial], hepatitis B vaccine/cb [Drug Combination], hepatitis B vaccine/dt [Drug Therapy], lamivudine/ct [Clinical Trial], lamivudine/cm [Drug Comparison], lamivudine/cr [Drug Concentration], lamivudine/dt [Drug Therapy], lamivudine/to [Drug Toxicity], peginterferon/dt [Drug Therapy], peginterferon alpha2a/dt [Drug Therapy], peginterferon alpha2a/to [Drug Toxicity], placebo, telbivudine/cm [Drug Comparison], telbivudine/dt [Drug Therapy], telbivudine/to [Drug Toxicity], tenofovir/ct [Clinical Trial], tenofovir/cr [Drug Concentration], tenofovir/dt [Drug Therapy], tenofovir/to [Drug Toxicity], tenofovir/sc [Subcutaneous Drug Administration], tenofovir alafenamide/cm [Drug Comparison], tenofovir alafenamide/po [Oral Drug Administration], tenofovir disoproxil/cm [Drug Comparison], tenofovir disoproxil/dt [Drug Therapy], tenofovir disoproxil/po [Oral Drug Administration], virus DNA, virus fusion inhibitor/dt [Drug Therapy], tenofovir disoproxil/cr [Drug Concentration], antiviral resistance, antiviral therapy, article, Australia, breast feeding, chronic hepatitis B/dt [Drug Therapy], disease exacerbation, drug blood level, drug milk level, drug safety, drug substitution, drug withdrawal, embryotoxicity, family planning, fetus malformation, follow up, hepatitis B/dr [Drug Resistance], hepatitis B/dt [Drug Therapy], hepatitis B/pc [Prevention], human, Human immunodeficiency virus infection/dt [Drug Therapy], immunoprophylaxis, liver fibrosis, New Zealand, nonhuman, obstetric procedure, patient education, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40050Test
Gut
Click here for full text options
LibKey Link

مصطلحات الفهرس: patient referral, pregnancy outcome, pregnant woman, prenatal screening, priority journal, puerperium, United Kingdom, vaccination, vertical transmission, virus load, virus transmission, adefovir/dt [Drug Therapy], adefovir/to [Drug Toxicity], entecavir/dt [Drug Therapy], entecavir/to [Drug Toxicity], hepatitis B antibody/ct [Clinical Trial], hepatitis B antibody/cb [Drug Combination], hepatitis B antibody/dt [Drug Therapy], hepatitis B surface antigen/ec [Endogenous Compound], hepatitis B vaccine/ct [Clinical Trial], hepatitis B vaccine/cb [Drug Combination], hepatitis B vaccine/dt [Drug Therapy], lamivudine/ct [Clinical Trial], lamivudine/cm [Drug Comparison], lamivudine/cr [Drug Concentration], lamivudine/dt [Drug Therapy], lamivudine/to [Drug Toxicity], peginterferon/dt [Drug Therapy], peginterferon alpha2a/dt [Drug Therapy], peginterferon alpha2a/to [Drug Toxicity], placebo, telbivudine/cm [Drug Comparison], telbivudine/dt [Drug Therapy], telbivudine/to [Drug Toxicity], tenofovir/ct [Clinical Trial], tenofovir/cr [Drug Concentration], tenofovir/dt [Drug Therapy], tenofovir/to [Drug Toxicity], tenofovir/sc [Subcutaneous Drug Administration], tenofovir alafenamide/cm [Drug Comparison], tenofovir alafenamide/po [Oral Drug Administration], tenofovir disoproxil/cm [Drug Comparison], tenofovir disoproxil/dt [Drug Therapy], tenofovir disoproxil/po [Oral Drug Administration], virus DNA, virus fusion inhibitor/dt [Drug Therapy], tenofovir disoproxil/cr [Drug Concentration], antiviral resistance, antiviral therapy, article, Australia, breast feeding, chronic hepatitis B/dt [Drug Therapy], disease exacerbation, drug blood level, drug milk level, drug safety, drug substitution, drug withdrawal, embryotoxicity, family planning, fetus malformation, follow up, hepatitis B/dr [Drug Resistance], hepatitis B/dt [Drug Therapy], hepatitis B/pc [Prevention], human, Human immunodeficiency virus infection/dt [Drug Therapy], immunoprophylaxis, liver fibrosis, New Zealand, nonhuman, obstetric procedure, patient education, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40050Test
Gut
LibKey Link

مصطلحات الفهرس: placental transfer, prenatal drug exposure, priority journal, reproductive toxicity, review, single drug dose, teratogenicity, virus transmission, adefovir/cm [Drug Comparison], adefovir dipivoxil/dt [Drug Therapy], adefovir dipivoxil/to [Drug Toxicity], adefovir dipivoxil/iv [Intravenous Drug Administration], adefovir dipivoxil/pd [Pharmacology], alpha interferon/cr [Drug Concentration], alpha interferon/dt [Drug Therapy], alpha interferon/to [Drug Toxicity], alpha interferon/im [Intramuscular Drug Administration], alpha interferon/iv [Intravenous Drug Administration], alpha interferon/pk [Pharmacokinetics], alpha interferon/pd [Pharmacology], entecavir/cm [Drug Comparison], entecavir/dt [Drug Therapy], entecavir/to [Drug Toxicity], entecavir/iv [Intravenous Drug Administration], entecavir/pk [Pharmacokinetics], entecavir/pd [Pharmacology], lamivudine/cm [Drug Comparison], lamivudine/cr [Drug Concentration], lamivudine/dt [Drug Therapy], lamivudine/to [Drug Toxicity], lamivudine/po [Oral Drug Administration], lamivudine/pk [Pharmacokinetics], lamivudine/pd [Pharmacology], placebo, telbivudine/cm [Drug Comparison], telbivudine/dt [Drug Therapy], telbivudine/to [Drug Toxicity], telbivudine/pk [Pharmacokinetics], telbivudine/pd [Pharmacology], tenofovir/cm [Drug Comparison], tenofovir/dt [Drug Therapy], tenofovir/to [Drug Toxicity], tenofovir/pk [Pharmacokinetics], tenofovir/pd [Pharmacology], tenofovir/sc [Subcutaneous Drug Administration], antiviral therapy, breast feeding, drug blood level, drug carcinogenicity, drug efficacy, drug excretion, drug milk level, fetotoxicity, hepatitis B/dt [Drug Therapy], human, intrauterine infection/dt [Drug Therapy], maternal blood, nonhuman, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30256Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: placental transfer, prenatal drug exposure, priority journal, reproductive toxicity, review, single drug dose, teratogenicity, virus transmission, adefovir/cm [Drug Comparison], adefovir dipivoxil/dt [Drug Therapy], adefovir dipivoxil/to [Drug Toxicity], adefovir dipivoxil/iv [Intravenous Drug Administration], adefovir dipivoxil/pd [Pharmacology], alpha interferon/cr [Drug Concentration], alpha interferon/dt [Drug Therapy], alpha interferon/to [Drug Toxicity], alpha interferon/im [Intramuscular Drug Administration], alpha interferon/iv [Intravenous Drug Administration], alpha interferon/pk [Pharmacokinetics], alpha interferon/pd [Pharmacology], entecavir/cm [Drug Comparison], entecavir/dt [Drug Therapy], entecavir/to [Drug Toxicity], entecavir/iv [Intravenous Drug Administration], entecavir/pk [Pharmacokinetics], entecavir/pd [Pharmacology], lamivudine/cm [Drug Comparison], lamivudine/cr [Drug Concentration], lamivudine/dt [Drug Therapy], lamivudine/to [Drug Toxicity], lamivudine/po [Oral Drug Administration], lamivudine/pk [Pharmacokinetics], lamivudine/pd [Pharmacology], placebo, telbivudine/cm [Drug Comparison], telbivudine/dt [Drug Therapy], telbivudine/to [Drug Toxicity], telbivudine/pk [Pharmacokinetics], telbivudine/pd [Pharmacology], tenofovir/cm [Drug Comparison], tenofovir/dt [Drug Therapy], tenofovir/to [Drug Toxicity], tenofovir/pk [Pharmacokinetics], tenofovir/pd [Pharmacology], tenofovir/sc [Subcutaneous Drug Administration], antiviral therapy, breast feeding, drug blood level, drug carcinogenicity, drug efficacy, drug excretion, drug milk level, fetotoxicity, hepatitis B/dt [Drug Therapy], human, intrauterine infection/dt [Drug Therapy], maternal blood, nonhuman, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30256Test
LibKey Link